Ignite Creation Date:
2024-05-06 @ 7:12 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02495415
Status:
UNKNOWN
Last Update Posted:
2019-07-23
First Post:
2015-07-07
Brief Title:
Trial of Intravenous Fenretinide Emulsion for Patients With RelapsedRefractory Peripheral T-cell Lymphomas
Sponsor:
CerRx Inc
Organization:
CerRx Inc
Organization Data
Organization:
CerRx Inc
Class:
INDUSTRY
Study ID:
FEN T-14
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CerRx Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None